First postlicensure season data show high RSV vaccine effectiveness against acute respiratory illness in older adults, including high-risk subgroups and severe outcomes, supporting broad uptake in ...

MUSCAT: The Respiratory Syncytial Virus (RSV) is witnessing a surge in cases, particularly among children under six months, ...

NNVC READ THE FULL NNVC RESEARCH REPORT Business Update Mpox Trial to Initiate in Late 2025/Early 2026 NanoViricides, Inc. (NYSE:NNVC) is planning to initiate a Phase 2 clinical trial for the ...

Researchers at the California Animal Health and Food Safety Laboratory said that the first reported commercial poultry case ...

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) report ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

The risk of human-to-human spread of the H5N8 strain of bird flu appears low after it was identified for the first time ...

SEONGNAM, South Korea, Oct. 15, 2025 /PRNewswire/ -- SK bioscience announced that it has submitted a Phase 1/2 clinical trial application in Australia for GBP511, a universal coronavirus vaccine ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease.

The president’s call for removal of the metal from childhood inoculations set off alarms. About half of shots for polio, whooping cough and other diseases would be affected. By Christina Jewett ...

A new working group of outside advisers to the US Centers for Disease Control and Prevention will convene to assess the safety, effectiveness and timing of the shots children and adolescents get, as ...